nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ATP4A—hematologic cancer	0.27	0.761	CbGaD
Rabeprazole—ABCG2—hematologic cancer	0.0847	0.238	CbGaD
Rabeprazole—ABCG2—Clofarabine—hematologic cancer	0.0222	0.0524	CbGbCtD
Rabeprazole—CYP1A2—Anagrelide—hematologic cancer	0.0132	0.0312	CbGbCtD
Rabeprazole—CYP1A1—Methoxsalen—hematologic cancer	0.0132	0.0312	CbGbCtD
Rabeprazole—ABCG2—Daunorubicin—hematologic cancer	0.013	0.0307	CbGbCtD
Rabeprazole—CYP1A1—Bortezomib—hematologic cancer	0.0126	0.0297	CbGbCtD
Rabeprazole—CYP1A1—Daunorubicin—hematologic cancer	0.012	0.0284	CbGbCtD
Rabeprazole—ABCG2—Teniposide—hematologic cancer	0.0113	0.0267	CbGbCtD
Rabeprazole—CYP1A1—Thalidomide—hematologic cancer	0.011	0.0258	CbGbCtD
Rabeprazole—ABCG2—Cladribine—hematologic cancer	0.0109	0.0256	CbGbCtD
Rabeprazole—ABCG2—Imatinib—hematologic cancer	0.00999	0.0235	CbGbCtD
Rabeprazole—CYP1A1—Dacarbazine—hematologic cancer	0.00943	0.0222	CbGbCtD
Rabeprazole—ABCG2—Nilotinib—hematologic cancer	0.00908	0.0214	CbGbCtD
Rabeprazole—CYP2C9—Bexarotene—hematologic cancer	0.00827	0.0195	CbGbCtD
Rabeprazole—ABCG2—Dasatinib—hematologic cancer	0.00802	0.0189	CbGbCtD
Rabeprazole—ABCG2—Mitoxantrone—hematologic cancer	0.00793	0.0187	CbGbCtD
Rabeprazole—CYP1A1—Dasatinib—hematologic cancer	0.00741	0.0175	CbGbCtD
Rabeprazole—CYP2D6—Lomustine—hematologic cancer	0.00703	0.0166	CbGbCtD
Rabeprazole—CYP1A2—Carmustine—hematologic cancer	0.00695	0.0164	CbGbCtD
Rabeprazole—CYP2C9—Idarubicin—hematologic cancer	0.00685	0.0161	CbGbCtD
Rabeprazole—CYP2D6—Idarubicin—hematologic cancer	0.00626	0.0148	CbGbCtD
Rabeprazole—ABCG2—Irinotecan—hematologic cancer	0.00624	0.0147	CbGbCtD
Rabeprazole—CYP2C19—Bortezomib—hematologic cancer	0.00609	0.0144	CbGbCtD
Rabeprazole—CYP1A2—Methoxsalen—hematologic cancer	0.00591	0.0139	CbGbCtD
Rabeprazole—CYP1A2—Bortezomib—hematologic cancer	0.00562	0.0132	CbGbCtD
Rabeprazole—ABCG2—Vincristine—hematologic cancer	0.00545	0.0129	CbGbCtD
Rabeprazole—CYP1A2—Daunorubicin—hematologic cancer	0.00538	0.0127	CbGbCtD
Rabeprazole—CYP2D6—Hydroxyurea—hematologic cancer	0.00533	0.0125	CbGbCtD
Rabeprazole—CYP2C19—Thalidomide—hematologic cancer	0.00531	0.0125	CbGbCtD
Rabeprazole—CYP1A2—Alitretinoin—hematologic cancer	0.00527	0.0124	CbGbCtD
Rabeprazole—ABCG2—Cisplatin—hematologic cancer	0.00509	0.012	CbGbCtD
Rabeprazole—CYP2C9—Bortezomib—hematologic cancer	0.00507	0.0119	CbGbCtD
Rabeprazole—CYP2C19—Teniposide—hematologic cancer	0.00506	0.0119	CbGbCtD
Rabeprazole—ABCG2—Etoposide—hematologic cancer	0.005	0.0118	CbGbCtD
Rabeprazole—CYP1A2—Thalidomide—hematologic cancer	0.0049	0.0115	CbGbCtD
Rabeprazole—CYP3A4—Bexarotene—hematologic cancer	0.00481	0.0113	CbGbCtD
Rabeprazole—CYP2C19—Ifosfamide—hematologic cancer	0.00467	0.011	CbGbCtD
Rabeprazole—CYP2D6—Bortezomib—hematologic cancer	0.00463	0.0109	CbGbCtD
Rabeprazole—CYP3A4—Lomustine—hematologic cancer	0.00447	0.0105	CbGbCtD
Rabeprazole—CYP3A4—Busulfan—hematologic cancer	0.00447	0.0105	CbGbCtD
Rabeprazole—CYP2C19—Imatinib—hematologic cancer	0.00446	0.0105	CbGbCtD
Rabeprazole—CYP2C9—Thalidomide—hematologic cancer	0.00441	0.0104	CbGbCtD
Rabeprazole—CYP1A2—Dacarbazine—hematologic cancer	0.00421	0.00993	CbGbCtD
Rabeprazole—CYP2C9—Teniposide—hematologic cancer	0.00421	0.00992	CbGbCtD
Rabeprazole—CYP1A2—Imatinib—hematologic cancer	0.00412	0.00971	CbGbCtD
Rabeprazole—ABCG2—Dexamethasone—hematologic cancer	0.00411	0.00968	CbGbCtD
Rabeprazole—CYP3A4—Thiotepa—hematologic cancer	0.00398	0.00938	CbGbCtD
Rabeprazole—CYP2C9—Ifosfamide—hematologic cancer	0.00389	0.00916	CbGbCtD
Rabeprazole—CYP1A1—Dexamethasone—hematologic cancer	0.00379	0.00894	CbGbCtD
Rabeprazole—CYP2C9—Imatinib—hematologic cancer	0.00371	0.00875	CbGbCtD
Rabeprazole—ABCG2—Doxorubicin—hematologic cancer	0.00341	0.00803	CbGbCtD
Rabeprazole—CYP2D6—Imatinib—hematologic cancer	0.00339	0.008	CbGbCtD
Rabeprazole—CYP2C9—Nilotinib—hematologic cancer	0.00337	0.00795	CbGbCtD
Rabeprazole—CYP1A2—Dasatinib—hematologic cancer	0.00331	0.0078	CbGbCtD
Rabeprazole—ABCG2—Methotrexate—hematologic cancer	0.0033	0.00778	CbGbCtD
Rabeprazole—CYP3A4—Methoxsalen—hematologic cancer	0.0031	0.0073	CbGbCtD
Rabeprazole—CYP2D6—Nilotinib—hematologic cancer	0.00308	0.00727	CbGbCtD
Rabeprazole—CYP2D6—Vinorelbine—hematologic cancer	0.00306	0.00721	CbGbCtD
Rabeprazole—CYP3A4—Bortezomib—hematologic cancer	0.00295	0.00694	CbGbCtD
Rabeprazole—CYP2C19—Prednisone—hematologic cancer	0.00294	0.00693	CbGbCtD
Rabeprazole—CYP3A4—Daunorubicin—hematologic cancer	0.00282	0.00664	CbGbCtD
Rabeprazole—CYP3A4—Cytarabine—hematologic cancer	0.00249	0.00586	CbGbCtD
Rabeprazole—CYP3A4—Teniposide—hematologic cancer	0.00245	0.00577	CbGbCtD
Rabeprazole—CYP3A4—Ifosfamide—hematologic cancer	0.00226	0.00532	CbGbCtD
Rabeprazole—CYP3A4—Imatinib—hematologic cancer	0.00216	0.00509	CbGbCtD
Rabeprazole—CYP1A2—Etoposide—hematologic cancer	0.00206	0.00486	CbGbCtD
Rabeprazole—CYP3A4—Ruxolitinib—hematologic cancer	0.00203	0.00479	CbGbCtD
Rabeprazole—CYP3A4—Nilotinib—hematologic cancer	0.00196	0.00462	CbGbCtD
Rabeprazole—CYP3A4—Vinorelbine—hematologic cancer	0.00195	0.00458	CbGbCtD
Rabeprazole—CYP2C9—Cisplatin—hematologic cancer	0.00189	0.00445	CbGbCtD
Rabeprazole—CYP2D6—Vinblastine—hematologic cancer	0.00189	0.00444	CbGbCtD
Rabeprazole—CYP2C19—Dexamethasone—hematologic cancer	0.00184	0.00433	CbGbCtD
Rabeprazole—CYP3A4—Triamcinolone—hematologic cancer	0.00178	0.00419	CbGbCtD
Rabeprazole—CYP3A4—Dasatinib—hematologic cancer	0.00173	0.00408	CbGbCtD
Rabeprazole—CYP3A4—Mitoxantrone—hematologic cancer	0.00171	0.00403	CbGbCtD
Rabeprazole—CYP2C9—Dexamethasone—hematologic cancer	0.00153	0.0036	CbGbCtD
Rabeprazole—CYP3A4—Betamethasone—hematologic cancer	0.00153	0.0036	CbGbCtD
Rabeprazole—CYP3A4—Prednisolone—hematologic cancer	0.00151	0.00355	CbGbCtD
Rabeprazole—CYP3A4—Prednisone—hematologic cancer	0.00142	0.00335	CbGbCtD
Rabeprazole—CYP2D6—Dexamethasone—hematologic cancer	0.0014	0.00329	CbGbCtD
Rabeprazole—CYP3A4—Irinotecan—hematologic cancer	0.00135	0.00318	CbGbCtD
Rabeprazole—CYP3A4—Vinblastine—hematologic cancer	0.0012	0.00282	CbGbCtD
Rabeprazole—CYP3A4—Vincristine—hematologic cancer	0.00118	0.00278	CbGbCtD
Rabeprazole—CYP2D6—Doxorubicin—hematologic cancer	0.00116	0.00273	CbGbCtD
Rabeprazole—CYP3A4—Etoposide—hematologic cancer	0.00108	0.00254	CbGbCtD
Rabeprazole—Esomeprazole—ATP4A—hematologic cancer	0.000913	0.247	CrCbGaD
Rabeprazole—ATP4A—hematopoietic system—hematologic cancer	0.000892	0.16	CbGeAlD
Rabeprazole—CYP3A4—Dexamethasone—hematologic cancer	0.000888	0.00209	CbGbCtD
Rabeprazole—CYP3A4—Doxorubicin—hematologic cancer	0.000737	0.00174	CbGbCtD
Rabeprazole—Pantoprazole—ATP4A—hematologic cancer	0.00066	0.178	CrCbGaD
Rabeprazole—ATP4A—blood—hematologic cancer	0.000591	0.106	CbGeAlD
Rabeprazole—Omeprazole—ATP4A—hematologic cancer	0.000538	0.145	CrCbGaD
Rabeprazole—Lansoprazole—ATP4A—hematologic cancer	0.000492	0.133	CrCbGaD
Rabeprazole—ATP4A—testis—hematologic cancer	0.000489	0.0876	CbGeAlD
Rabeprazole—Omeprazole—ABCC3—hematologic cancer	0.000347	0.0937	CrCbGaD
Rabeprazole—CYP2C19—hematopoietic system—hematologic cancer	0.000312	0.0558	CbGeAlD
Rabeprazole—CYP1A2—hematopoietic system—hematologic cancer	0.000255	0.0456	CbGeAlD
Rabeprazole—CYP1A1—hematopoietic system—hematologic cancer	0.000251	0.045	CbGeAlD
Rabeprazole—CYP2C9—hematopoietic system—hematologic cancer	0.000242	0.0433	CbGeAlD
Rabeprazole—Pantoprazole—ABCG2—hematologic cancer	0.000207	0.0558	CrCbGaD
Rabeprazole—CYP2C19—blood—hematologic cancer	0.000206	0.037	CbGeAlD
Rabeprazole—CYP3A4—hematopoietic system—hematologic cancer	0.000184	0.033	CbGeAlD
Rabeprazole—CYP2D6—hematopoietic system—hematologic cancer	0.000181	0.0325	CbGeAlD
Rabeprazole—ABCG2—blood—hematologic cancer	0.000175	0.0314	CbGeAlD
Rabeprazole—ABCG2—bone marrow—hematologic cancer	0.00017	0.0304	CbGeAlD
Rabeprazole—CYP1A2—blood—hematologic cancer	0.000169	0.0302	CbGeAlD
Rabeprazole—Omeprazole—ABCG2—hematologic cancer	0.000169	0.0455	CrCbGaD
Rabeprazole—CYP1A1—blood—hematologic cancer	0.000166	0.0298	CbGeAlD
Rabeprazole—CYP2C9—blood—hematologic cancer	0.00016	0.0287	CbGeAlD
Rabeprazole—Lansoprazole—ABCG2—hematologic cancer	0.000154	0.0416	CrCbGaD
Rabeprazole—ABCG2—lung—hematologic cancer	0.000154	0.0275	CbGeAlD
Rabeprazole—CYP1A2—lung—hematologic cancer	0.000148	0.0265	CbGeAlD
Rabeprazole—CYP1A1—lung—hematologic cancer	0.000146	0.0261	CbGeAlD
Rabeprazole—ABCG2—testis—hematologic cancer	0.000145	0.026	CbGeAlD
Rabeprazole—CYP3A4—blood—hematologic cancer	0.000122	0.0219	CbGeAlD
Rabeprazole—CYP2D6—blood—hematologic cancer	0.00012	0.0215	CbGeAlD
Rabeprazole—ABCG2—lymph node—hematologic cancer	0.000105	0.0188	CbGeAlD
Rabeprazole—CYP1A1—lymph node—hematologic cancer	9.97e-05	0.0179	CbGeAlD
Rabeprazole—CYP2D6—testis—hematologic cancer	9.93e-05	0.0178	CbGeAlD
Rabeprazole—Pantoprazole—ABCB1—hematologic cancer	8.6e-05	0.0232	CrCbGaD
Rabeprazole—Omeprazole—ABCB1—hematologic cancer	7.01e-05	0.0189	CrCbGaD
Rabeprazole—Lansoprazole—ABCB1—hematologic cancer	6.41e-05	0.0173	CrCbGaD
Rabeprazole—Pain—Betamethasone—hematologic cancer	9.64e-06	5.64e-05	CcSEcCtD
Rabeprazole—Pain—Dexamethasone—hematologic cancer	9.64e-06	5.64e-05	CcSEcCtD
Rabeprazole—Visual impairment—Doxorubicin—hematologic cancer	9.64e-06	5.64e-05	CcSEcCtD
Rabeprazole—Tachycardia—Prednisone—hematologic cancer	9.58e-06	5.6e-05	CcSEcCtD
Rabeprazole—Alopecia—Epirubicin—hematologic cancer	9.55e-06	5.59e-05	CcSEcCtD
Rabeprazole—Nausea—Gemcitabine—hematologic cancer	9.53e-06	5.57e-05	CcSEcCtD
Rabeprazole—Vomiting—Cisplatin—hematologic cancer	9.51e-06	5.56e-05	CcSEcCtD
Rabeprazole—Hyperhidrosis—Prednisone—hematologic cancer	9.49e-06	5.55e-05	CcSEcCtD
Rabeprazole—Vision blurred—Methotrexate—hematologic cancer	9.48e-06	5.54e-05	CcSEcCtD
Rabeprazole—Erythema multiforme—Doxorubicin—hematologic cancer	9.46e-06	5.53e-05	CcSEcCtD
Rabeprazole—Rash—Cisplatin—hematologic cancer	9.43e-06	5.51e-05	CcSEcCtD
Rabeprazole—Dermatitis—Cisplatin—hematologic cancer	9.42e-06	5.51e-05	CcSEcCtD
Rabeprazole—Malnutrition—Epirubicin—hematologic cancer	9.41e-06	5.5e-05	CcSEcCtD
Rabeprazole—Erythema—Epirubicin—hematologic cancer	9.41e-06	5.5e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Etoposide—hematologic cancer	9.37e-06	5.48e-05	CcSEcCtD
Rabeprazole—Anorexia—Prednisone—hematologic cancer	9.36e-06	5.47e-05	CcSEcCtD
Rabeprazole—Eye disorder—Doxorubicin—hematologic cancer	9.35e-06	5.47e-05	CcSEcCtD
Rabeprazole—Ill-defined disorder—Methotrexate—hematologic cancer	9.33e-06	5.46e-05	CcSEcCtD
Rabeprazole—Tinnitus—Doxorubicin—hematologic cancer	9.33e-06	5.45e-05	CcSEcCtD
Rabeprazole—Anaemia—Methotrexate—hematologic cancer	9.29e-06	5.43e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Dexamethasone—hematologic cancer	9.29e-06	5.43e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Betamethasone—hematologic cancer	9.29e-06	5.43e-05	CcSEcCtD
Rabeprazole—Flatulence—Epirubicin—hematologic cancer	9.27e-06	5.42e-05	CcSEcCtD
Rabeprazole—Tension—Epirubicin—hematologic cancer	9.23e-06	5.4e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Betamethasone—hematologic cancer	9.22e-06	5.39e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Dexamethasone—hematologic cancer	9.22e-06	5.39e-05	CcSEcCtD
Rabeprazole—Dysgeusia—Epirubicin—hematologic cancer	9.21e-06	5.39e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Triamcinolone—hematologic cancer	9.16e-06	5.35e-05	CcSEcCtD
Rabeprazole—Nervousness—Epirubicin—hematologic cancer	9.14e-06	5.34e-05	CcSEcCtD
Rabeprazole—Back pain—Epirubicin—hematologic cancer	9.1e-06	5.32e-05	CcSEcCtD
Rabeprazole—Angiopathy—Doxorubicin—hematologic cancer	9.07e-06	5.31e-05	CcSEcCtD
Rabeprazole—Malaise—Methotrexate—hematologic cancer	9.07e-06	5.3e-05	CcSEcCtD
Rabeprazole—Dizziness—Etoposide—hematologic cancer	9.06e-06	5.3e-05	CcSEcCtD
Rabeprazole—Muscle spasms—Epirubicin—hematologic cancer	9.05e-06	5.29e-05	CcSEcCtD
Rabeprazole—Vertigo—Methotrexate—hematologic cancer	9.03e-06	5.28e-05	CcSEcCtD
Rabeprazole—Leukopenia—Methotrexate—hematologic cancer	9e-06	5.26e-05	CcSEcCtD
Rabeprazole—Chills—Doxorubicin—hematologic cancer	8.97e-06	5.25e-05	CcSEcCtD
Rabeprazole—Urticaria—Dexamethasone—hematologic cancer	8.96e-06	5.24e-05	CcSEcCtD
Rabeprazole—Urticaria—Betamethasone—hematologic cancer	8.96e-06	5.24e-05	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Prednisone—hematologic cancer	8.95e-06	5.23e-05	CcSEcCtD
Rabeprazole—Dizziness—Prednisolone—hematologic cancer	8.94e-06	5.23e-05	CcSEcCtD
Rabeprazole—Arrhythmia—Doxorubicin—hematologic cancer	8.93e-06	5.22e-05	CcSEcCtD
Rabeprazole—Asthenia—Triamcinolone—hematologic cancer	8.92e-06	5.21e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Dexamethasone—hematologic cancer	8.91e-06	5.21e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Betamethasone—hematologic cancer	8.91e-06	5.21e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Dexamethasone—hematologic cancer	8.91e-06	5.21e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Betamethasone—hematologic cancer	8.91e-06	5.21e-05	CcSEcCtD
Rabeprazole—Nausea—Cisplatin—hematologic cancer	8.88e-06	5.19e-05	CcSEcCtD
Rabeprazole—Insomnia—Prednisone—hematologic cancer	8.88e-06	5.19e-05	CcSEcCtD
Rabeprazole—Vision blurred—Epirubicin—hematologic cancer	8.87e-06	5.19e-05	CcSEcCtD
Rabeprazole—Alopecia—Doxorubicin—hematologic cancer	8.84e-06	5.17e-05	CcSEcCtD
Rabeprazole—Paraesthesia—Prednisone—hematologic cancer	8.82e-06	5.16e-05	CcSEcCtD
Rabeprazole—Pruritus—Triamcinolone—hematologic cancer	8.79e-06	5.14e-05	CcSEcCtD
Rabeprazole—Cough—Methotrexate—hematologic cancer	8.77e-06	5.13e-05	CcSEcCtD
Rabeprazole—Ill-defined disorder—Epirubicin—hematologic cancer	8.73e-06	5.11e-05	CcSEcCtD
Rabeprazole—Convulsion—Methotrexate—hematologic cancer	8.71e-06	5.09e-05	CcSEcCtD
Rabeprazole—Vomiting—Etoposide—hematologic cancer	8.71e-06	5.09e-05	CcSEcCtD
Rabeprazole—Erythema—Doxorubicin—hematologic cancer	8.71e-06	5.09e-05	CcSEcCtD
Rabeprazole—Malnutrition—Doxorubicin—hematologic cancer	8.71e-06	5.09e-05	CcSEcCtD
Rabeprazole—Anaemia—Epirubicin—hematologic cancer	8.7e-06	5.09e-05	CcSEcCtD
Rabeprazole—Agitation—Epirubicin—hematologic cancer	8.65e-06	5.06e-05	CcSEcCtD
Rabeprazole—Dyspepsia—Prednisone—hematologic cancer	8.64e-06	5.05e-05	CcSEcCtD
Rabeprazole—Rash—Etoposide—hematologic cancer	8.64e-06	5.05e-05	CcSEcCtD
Rabeprazole—Dermatitis—Etoposide—hematologic cancer	8.63e-06	5.05e-05	CcSEcCtD
Rabeprazole—Headache—Etoposide—hematologic cancer	8.58e-06	5.02e-05	CcSEcCtD
Rabeprazole—Flatulence—Doxorubicin—hematologic cancer	8.58e-06	5.02e-05	CcSEcCtD
Rabeprazole—Chest pain—Methotrexate—hematologic cancer	8.56e-06	5.01e-05	CcSEcCtD
Rabeprazole—Arthralgia—Methotrexate—hematologic cancer	8.56e-06	5.01e-05	CcSEcCtD
Rabeprazole—Myalgia—Methotrexate—hematologic cancer	8.56e-06	5.01e-05	CcSEcCtD
Rabeprazole—Tension—Doxorubicin—hematologic cancer	8.54e-06	5e-05	CcSEcCtD
Rabeprazole—Decreased appetite—Prednisone—hematologic cancer	8.54e-06	4.99e-05	CcSEcCtD
Rabeprazole—Dysgeusia—Doxorubicin—hematologic cancer	8.53e-06	4.99e-05	CcSEcCtD
Rabeprazole—Rash—Prednisolone—hematologic cancer	8.52e-06	4.98e-05	CcSEcCtD
Rabeprazole—Dermatitis—Prednisolone—hematologic cancer	8.51e-06	4.98e-05	CcSEcCtD
Rabeprazole—Malaise—Epirubicin—hematologic cancer	8.49e-06	4.96e-05	CcSEcCtD
Rabeprazole—Headache—Prednisolone—hematologic cancer	8.47e-06	4.95e-05	CcSEcCtD
Rabeprazole—Discomfort—Methotrexate—hematologic cancer	8.46e-06	4.95e-05	CcSEcCtD
Rabeprazole—Nervousness—Doxorubicin—hematologic cancer	8.46e-06	4.95e-05	CcSEcCtD
Rabeprazole—Vertigo—Epirubicin—hematologic cancer	8.45e-06	4.94e-05	CcSEcCtD
Rabeprazole—Syncope—Epirubicin—hematologic cancer	8.44e-06	4.93e-05	CcSEcCtD
Rabeprazole—Leukopenia—Epirubicin—hematologic cancer	8.42e-06	4.93e-05	CcSEcCtD
Rabeprazole—Back pain—Doxorubicin—hematologic cancer	8.42e-06	4.92e-05	CcSEcCtD
Rabeprazole—Constipation—Prednisone—hematologic cancer	8.4e-06	4.91e-05	CcSEcCtD
Rabeprazole—Muscle spasms—Doxorubicin—hematologic cancer	8.37e-06	4.9e-05	CcSEcCtD
Rabeprazole—Palpitations—Epirubicin—hematologic cancer	8.32e-06	4.86e-05	CcSEcCtD
Rabeprazole—Confusional state—Methotrexate—hematologic cancer	8.27e-06	4.84e-05	CcSEcCtD
Rabeprazole—Loss of consciousness—Epirubicin—hematologic cancer	8.27e-06	4.84e-05	CcSEcCtD
Rabeprazole—Dizziness—Triamcinolone—hematologic cancer	8.22e-06	4.81e-05	CcSEcCtD
Rabeprazole—Cough—Epirubicin—hematologic cancer	8.21e-06	4.8e-05	CcSEcCtD
Rabeprazole—Anaphylactic shock—Methotrexate—hematologic cancer	8.21e-06	4.8e-05	CcSEcCtD
Rabeprazole—Vision blurred—Doxorubicin—hematologic cancer	8.21e-06	4.8e-05	CcSEcCtD
Rabeprazole—Convulsion—Epirubicin—hematologic cancer	8.15e-06	4.77e-05	CcSEcCtD
Rabeprazole—Nausea—Etoposide—hematologic cancer	8.14e-06	4.76e-05	CcSEcCtD
Rabeprazole—Hypertension—Epirubicin—hematologic cancer	8.12e-06	4.75e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Prednisone—hematologic cancer	8.09e-06	4.73e-05	CcSEcCtD
Rabeprazole—Asthenia—Dexamethasone—hematologic cancer	8.09e-06	4.73e-05	CcSEcCtD
Rabeprazole—Asthenia—Betamethasone—hematologic cancer	8.09e-06	4.73e-05	CcSEcCtD
Rabeprazole—Ill-defined disorder—Doxorubicin—hematologic cancer	8.08e-06	4.72e-05	CcSEcCtD
Rabeprazole—Anaemia—Doxorubicin—hematologic cancer	8.05e-06	4.71e-05	CcSEcCtD
Rabeprazole—Thrombocytopenia—Methotrexate—hematologic cancer	8.03e-06	4.7e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Prednisone—hematologic cancer	8.03e-06	4.7e-05	CcSEcCtD
Rabeprazole—Nausea—Prednisolone—hematologic cancer	8.03e-06	4.69e-05	CcSEcCtD
Rabeprazole—Myalgia—Epirubicin—hematologic cancer	8.01e-06	4.68e-05	CcSEcCtD
Rabeprazole—Chest pain—Epirubicin—hematologic cancer	8.01e-06	4.68e-05	CcSEcCtD
Rabeprazole—Arthralgia—Epirubicin—hematologic cancer	8.01e-06	4.68e-05	CcSEcCtD
Rabeprazole—Agitation—Doxorubicin—hematologic cancer	8e-06	4.68e-05	CcSEcCtD
Rabeprazole—Anxiety—Epirubicin—hematologic cancer	7.98e-06	4.67e-05	CcSEcCtD
Rabeprazole—Pruritus—Dexamethasone—hematologic cancer	7.98e-06	4.66e-05	CcSEcCtD
Rabeprazole—Pruritus—Betamethasone—hematologic cancer	7.98e-06	4.66e-05	CcSEcCtD
Rabeprazole—Hyperhidrosis—Methotrexate—hematologic cancer	7.93e-06	4.64e-05	CcSEcCtD
Rabeprazole—Discomfort—Epirubicin—hematologic cancer	7.91e-06	4.63e-05	CcSEcCtD
Rabeprazole—Vomiting—Triamcinolone—hematologic cancer	7.9e-06	4.62e-05	CcSEcCtD
Rabeprazole—Malaise—Doxorubicin—hematologic cancer	7.85e-06	4.59e-05	CcSEcCtD
Rabeprazole—Rash—Triamcinolone—hematologic cancer	7.83e-06	4.58e-05	CcSEcCtD
Rabeprazole—Dry mouth—Epirubicin—hematologic cancer	7.83e-06	4.58e-05	CcSEcCtD
Rabeprazole—Dermatitis—Triamcinolone—hematologic cancer	7.83e-06	4.58e-05	CcSEcCtD
Rabeprazole—Vertigo—Doxorubicin—hematologic cancer	7.82e-06	4.57e-05	CcSEcCtD
Rabeprazole—Anorexia—Methotrexate—hematologic cancer	7.82e-06	4.57e-05	CcSEcCtD
Rabeprazole—Syncope—Doxorubicin—hematologic cancer	7.81e-06	4.57e-05	CcSEcCtD
Rabeprazole—Urticaria—Prednisone—hematologic cancer	7.8e-06	4.56e-05	CcSEcCtD
Rabeprazole—Leukopenia—Doxorubicin—hematologic cancer	7.79e-06	4.56e-05	CcSEcCtD
Rabeprazole—Headache—Triamcinolone—hematologic cancer	7.78e-06	4.55e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Prednisone—hematologic cancer	7.76e-06	4.54e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Prednisone—hematologic cancer	7.76e-06	4.54e-05	CcSEcCtD
Rabeprazole—Confusional state—Epirubicin—hematologic cancer	7.74e-06	4.53e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Dexamethasone—hematologic cancer	7.71e-06	4.51e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Betamethasone—hematologic cancer	7.71e-06	4.51e-05	CcSEcCtD
Rabeprazole—Palpitations—Doxorubicin—hematologic cancer	7.69e-06	4.5e-05	CcSEcCtD
Rabeprazole—Oedema—Epirubicin—hematologic cancer	7.68e-06	4.49e-05	CcSEcCtD
Rabeprazole—Anaphylactic shock—Epirubicin—hematologic cancer	7.68e-06	4.49e-05	CcSEcCtD
Rabeprazole—Hypotension—Methotrexate—hematologic cancer	7.67e-06	4.48e-05	CcSEcCtD
Rabeprazole—Loss of consciousness—Doxorubicin—hematologic cancer	7.65e-06	4.47e-05	CcSEcCtD
Rabeprazole—Cough—Doxorubicin—hematologic cancer	7.6e-06	4.44e-05	CcSEcCtD
Rabeprazole—Shock—Epirubicin—hematologic cancer	7.56e-06	4.42e-05	CcSEcCtD
Rabeprazole—Convulsion—Doxorubicin—hematologic cancer	7.54e-06	4.41e-05	CcSEcCtD
Rabeprazole—Thrombocytopenia—Epirubicin—hematologic cancer	7.52e-06	4.4e-05	CcSEcCtD
Rabeprazole—Hypertension—Doxorubicin—hematologic cancer	7.52e-06	4.4e-05	CcSEcCtD
Rabeprazole—Tachycardia—Epirubicin—hematologic cancer	7.5e-06	4.38e-05	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Methotrexate—hematologic cancer	7.48e-06	4.37e-05	CcSEcCtD
Rabeprazole—Dizziness—Betamethasone—hematologic cancer	7.46e-06	4.36e-05	CcSEcCtD
Rabeprazole—Dizziness—Dexamethasone—hematologic cancer	7.46e-06	4.36e-05	CcSEcCtD
Rabeprazole—Hyperhidrosis—Epirubicin—hematologic cancer	7.42e-06	4.34e-05	CcSEcCtD
Rabeprazole—Insomnia—Methotrexate—hematologic cancer	7.42e-06	4.34e-05	CcSEcCtD
Rabeprazole—Myalgia—Doxorubicin—hematologic cancer	7.41e-06	4.33e-05	CcSEcCtD
Rabeprazole—Arthralgia—Doxorubicin—hematologic cancer	7.41e-06	4.33e-05	CcSEcCtD
Rabeprazole—Chest pain—Doxorubicin—hematologic cancer	7.41e-06	4.33e-05	CcSEcCtD
Rabeprazole—Anxiety—Doxorubicin—hematologic cancer	7.39e-06	4.32e-05	CcSEcCtD
Rabeprazole—Nausea—Triamcinolone—hematologic cancer	7.38e-06	4.32e-05	CcSEcCtD
Rabeprazole—Paraesthesia—Methotrexate—hematologic cancer	7.37e-06	4.31e-05	CcSEcCtD
Rabeprazole—Discomfort—Doxorubicin—hematologic cancer	7.32e-06	4.28e-05	CcSEcCtD
Rabeprazole—Anorexia—Epirubicin—hematologic cancer	7.32e-06	4.28e-05	CcSEcCtD
Rabeprazole—Dyspnoea—Methotrexate—hematologic cancer	7.32e-06	4.28e-05	CcSEcCtD
Rabeprazole—Somnolence—Methotrexate—hematologic cancer	7.3e-06	4.27e-05	CcSEcCtD
Rabeprazole—Dry mouth—Doxorubicin—hematologic cancer	7.25e-06	4.24e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Prednisone—hematologic cancer	7.23e-06	4.23e-05	CcSEcCtD
Rabeprazole—Dyspepsia—Methotrexate—hematologic cancer	7.22e-06	4.22e-05	CcSEcCtD
Rabeprazole—Hypotension—Epirubicin—hematologic cancer	7.18e-06	4.2e-05	CcSEcCtD
Rabeprazole—Vomiting—Dexamethasone—hematologic cancer	7.17e-06	4.19e-05	CcSEcCtD
Rabeprazole—Vomiting—Betamethasone—hematologic cancer	7.17e-06	4.19e-05	CcSEcCtD
Rabeprazole—Confusional state—Doxorubicin—hematologic cancer	7.16e-06	4.19e-05	CcSEcCtD
Rabeprazole—Decreased appetite—Methotrexate—hematologic cancer	7.13e-06	4.17e-05	CcSEcCtD
Rabeprazole—Rash—Dexamethasone—hematologic cancer	7.11e-06	4.16e-05	CcSEcCtD
Rabeprazole—Rash—Betamethasone—hematologic cancer	7.11e-06	4.16e-05	CcSEcCtD
Rabeprazole—Anaphylactic shock—Doxorubicin—hematologic cancer	7.11e-06	4.16e-05	CcSEcCtD
Rabeprazole—Oedema—Doxorubicin—hematologic cancer	7.11e-06	4.16e-05	CcSEcCtD
Rabeprazole—Dermatitis—Dexamethasone—hematologic cancer	7.1e-06	4.15e-05	CcSEcCtD
Rabeprazole—Dermatitis—Betamethasone—hematologic cancer	7.1e-06	4.15e-05	CcSEcCtD
Rabeprazole—Headache—Dexamethasone—hematologic cancer	7.06e-06	4.13e-05	CcSEcCtD
Rabeprazole—Headache—Betamethasone—hematologic cancer	7.06e-06	4.13e-05	CcSEcCtD
Rabeprazole—Asthenia—Prednisone—hematologic cancer	7.04e-06	4.12e-05	CcSEcCtD
Rabeprazole—Pain—Methotrexate—hematologic cancer	7.02e-06	4.1e-05	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Epirubicin—hematologic cancer	7e-06	4.09e-05	CcSEcCtD
Rabeprazole—Shock—Doxorubicin—hematologic cancer	6.99e-06	4.09e-05	CcSEcCtD
Rabeprazole—Thrombocytopenia—Doxorubicin—hematologic cancer	6.96e-06	4.07e-05	CcSEcCtD
Rabeprazole—Pruritus—Prednisone—hematologic cancer	6.95e-06	4.06e-05	CcSEcCtD
Rabeprazole—Insomnia—Epirubicin—hematologic cancer	6.95e-06	4.06e-05	CcSEcCtD
Rabeprazole—Tachycardia—Doxorubicin—hematologic cancer	6.93e-06	4.06e-05	CcSEcCtD
Rabeprazole—Paraesthesia—Epirubicin—hematologic cancer	6.9e-06	4.03e-05	CcSEcCtD
Rabeprazole—Hyperhidrosis—Doxorubicin—hematologic cancer	6.87e-06	4.02e-05	CcSEcCtD
Rabeprazole—Dyspnoea—Epirubicin—hematologic cancer	6.85e-06	4e-05	CcSEcCtD
Rabeprazole—Somnolence—Epirubicin—hematologic cancer	6.83e-06	3.99e-05	CcSEcCtD
Rabeprazole—Anorexia—Doxorubicin—hematologic cancer	6.77e-06	3.96e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Methotrexate—hematologic cancer	6.76e-06	3.95e-05	CcSEcCtD
Rabeprazole—Dyspepsia—Epirubicin—hematologic cancer	6.76e-06	3.95e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Prednisone—hematologic cancer	6.72e-06	3.93e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Methotrexate—hematologic cancer	6.71e-06	3.92e-05	CcSEcCtD
Rabeprazole—Nausea—Dexamethasone—hematologic cancer	6.7e-06	3.92e-05	CcSEcCtD
Rabeprazole—Nausea—Betamethasone—hematologic cancer	6.7e-06	3.92e-05	CcSEcCtD
Rabeprazole—Decreased appetite—Epirubicin—hematologic cancer	6.68e-06	3.9e-05	CcSEcCtD
Rabeprazole—Hypotension—Doxorubicin—hematologic cancer	6.64e-06	3.88e-05	CcSEcCtD
Rabeprazole—Constipation—Epirubicin—hematologic cancer	6.57e-06	3.84e-05	CcSEcCtD
Rabeprazole—Pain—Epirubicin—hematologic cancer	6.57e-06	3.84e-05	CcSEcCtD
Rabeprazole—Urticaria—Methotrexate—hematologic cancer	6.52e-06	3.81e-05	CcSEcCtD
Rabeprazole—Dizziness—Prednisone—hematologic cancer	6.49e-06	3.8e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Methotrexate—hematologic cancer	6.49e-06	3.79e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Methotrexate—hematologic cancer	6.49e-06	3.79e-05	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	6.47e-06	3.79e-05	CcSEcCtD
Rabeprazole—Insomnia—Doxorubicin—hematologic cancer	6.43e-06	3.76e-05	CcSEcCtD
Rabeprazole—Paraesthesia—Doxorubicin—hematologic cancer	6.38e-06	3.73e-05	CcSEcCtD
Rabeprazole—Dyspnoea—Doxorubicin—hematologic cancer	6.33e-06	3.7e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Epirubicin—hematologic cancer	6.33e-06	3.7e-05	CcSEcCtD
Rabeprazole—Somnolence—Doxorubicin—hematologic cancer	6.32e-06	3.69e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Epirubicin—hematologic cancer	6.28e-06	3.67e-05	CcSEcCtD
Rabeprazole—Dyspepsia—Doxorubicin—hematologic cancer	6.25e-06	3.66e-05	CcSEcCtD
Rabeprazole—Vomiting—Prednisone—hematologic cancer	6.24e-06	3.65e-05	CcSEcCtD
Rabeprazole—Rash—Prednisone—hematologic cancer	6.19e-06	3.62e-05	CcSEcCtD
Rabeprazole—Dermatitis—Prednisone—hematologic cancer	6.19e-06	3.62e-05	CcSEcCtD
Rabeprazole—Decreased appetite—Doxorubicin—hematologic cancer	6.18e-06	3.61e-05	CcSEcCtD
Rabeprazole—Headache—Prednisone—hematologic cancer	6.15e-06	3.6e-05	CcSEcCtD
Rabeprazole—Urticaria—Epirubicin—hematologic cancer	6.1e-06	3.57e-05	CcSEcCtD
Rabeprazole—Pain—Doxorubicin—hematologic cancer	6.08e-06	3.55e-05	CcSEcCtD
Rabeprazole—Constipation—Doxorubicin—hematologic cancer	6.08e-06	3.55e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Epirubicin—hematologic cancer	6.07e-06	3.55e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Epirubicin—hematologic cancer	6.07e-06	3.55e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Methotrexate—hematologic cancer	6.05e-06	3.54e-05	CcSEcCtD
Rabeprazole—Asthenia—Methotrexate—hematologic cancer	5.89e-06	3.44e-05	CcSEcCtD
Rabeprazole—Feeling abnormal—Doxorubicin—hematologic cancer	5.86e-06	3.42e-05	CcSEcCtD
Rabeprazole—Nausea—Prednisone—hematologic cancer	5.83e-06	3.41e-05	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Doxorubicin—hematologic cancer	5.81e-06	3.4e-05	CcSEcCtD
Rabeprazole—Pruritus—Methotrexate—hematologic cancer	5.81e-06	3.4e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Epirubicin—hematologic cancer	5.66e-06	3.31e-05	CcSEcCtD
Rabeprazole—Urticaria—Doxorubicin—hematologic cancer	5.64e-06	3.3e-05	CcSEcCtD
Rabeprazole—Body temperature increased—Doxorubicin—hematologic cancer	5.62e-06	3.28e-05	CcSEcCtD
Rabeprazole—Abdominal pain—Doxorubicin—hematologic cancer	5.62e-06	3.28e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Methotrexate—hematologic cancer	5.61e-06	3.28e-05	CcSEcCtD
Rabeprazole—Asthenia—Epirubicin—hematologic cancer	5.51e-06	3.22e-05	CcSEcCtD
Rabeprazole—Pruritus—Epirubicin—hematologic cancer	5.43e-06	3.18e-05	CcSEcCtD
Rabeprazole—Dizziness—Methotrexate—hematologic cancer	5.43e-06	3.17e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Epirubicin—hematologic cancer	5.25e-06	3.07e-05	CcSEcCtD
Rabeprazole—Hypersensitivity—Doxorubicin—hematologic cancer	5.24e-06	3.06e-05	CcSEcCtD
Rabeprazole—Vomiting—Methotrexate—hematologic cancer	5.22e-06	3.05e-05	CcSEcCtD
Rabeprazole—Rash—Methotrexate—hematologic cancer	5.17e-06	3.03e-05	CcSEcCtD
Rabeprazole—Dermatitis—Methotrexate—hematologic cancer	5.17e-06	3.02e-05	CcSEcCtD
Rabeprazole—Headache—Methotrexate—hematologic cancer	5.14e-06	3.01e-05	CcSEcCtD
Rabeprazole—Asthenia—Doxorubicin—hematologic cancer	5.1e-06	2.98e-05	CcSEcCtD
Rabeprazole—Dizziness—Epirubicin—hematologic cancer	5.08e-06	2.97e-05	CcSEcCtD
Rabeprazole—Pruritus—Doxorubicin—hematologic cancer	5.03e-06	2.94e-05	CcSEcCtD
Rabeprazole—Vomiting—Epirubicin—hematologic cancer	4.88e-06	2.86e-05	CcSEcCtD
Rabeprazole—Nausea—Methotrexate—hematologic cancer	4.87e-06	2.85e-05	CcSEcCtD
Rabeprazole—Diarrhoea—Doxorubicin—hematologic cancer	4.86e-06	2.84e-05	CcSEcCtD
Rabeprazole—Rash—Epirubicin—hematologic cancer	4.84e-06	2.83e-05	CcSEcCtD
Rabeprazole—Dermatitis—Epirubicin—hematologic cancer	4.84e-06	2.83e-05	CcSEcCtD
Rabeprazole—Headache—Epirubicin—hematologic cancer	4.81e-06	2.81e-05	CcSEcCtD
Rabeprazole—Dizziness—Doxorubicin—hematologic cancer	4.7e-06	2.75e-05	CcSEcCtD
Rabeprazole—Nausea—Epirubicin—hematologic cancer	4.56e-06	2.67e-05	CcSEcCtD
Rabeprazole—Vomiting—Doxorubicin—hematologic cancer	4.52e-06	2.64e-05	CcSEcCtD
Rabeprazole—Rash—Doxorubicin—hematologic cancer	4.48e-06	2.62e-05	CcSEcCtD
Rabeprazole—Dermatitis—Doxorubicin—hematologic cancer	4.48e-06	2.62e-05	CcSEcCtD
Rabeprazole—Headache—Doxorubicin—hematologic cancer	4.45e-06	2.6e-05	CcSEcCtD
Rabeprazole—CYP2C9—Metabolism—TXN—hematologic cancer	4.27e-06	0.000106	CbGpPWpGaD
Rabeprazole—Nausea—Doxorubicin—hematologic cancer	4.22e-06	2.47e-05	CcSEcCtD
Rabeprazole—CYP2D6—Metabolism—SPHK1—hematologic cancer	4.22e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SPHK1—hematologic cancer	4.18e-06	0.000104	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—NCOR1—hematologic cancer	4.18e-06	0.000104	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTM1—hematologic cancer	4.18e-06	0.000104	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALOX5—hematologic cancer	4.18e-06	0.000104	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.15e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.09e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—UGT1A1—hematologic cancer	4.05e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	4.05e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NUP98—hematologic cancer	4.05e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ARNTL—hematologic cancer	4.04e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—UGT1A1—hematologic cancer	4.02e-06	0.0001	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTAP—hematologic cancer	4e-06	9.97e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC22A1—hematologic cancer	3.94e-06	9.83e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CRABP1—hematologic cancer	3.94e-06	9.83e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CA9—hematologic cancer	3.93e-06	9.79e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ACP5—hematologic cancer	3.93e-06	9.79e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ADCY7—hematologic cancer	3.93e-06	9.79e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NCOA3—hematologic cancer	3.93e-06	9.79e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.92e-06	9.76e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC22A1—hematologic cancer	3.91e-06	9.74e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CRABP1—hematologic cancer	3.91e-06	9.74e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NUP214—hematologic cancer	3.9e-06	9.72e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NCOR2—hematologic cancer	3.88e-06	9.66e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.86e-06	9.62e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALOX5—hematologic cancer	3.84e-06	9.57e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ABCG2—hematologic cancer	3.82e-06	9.52e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—MTR—hematologic cancer	3.82e-06	9.52e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALOX5—hematologic cancer	3.81e-06	9.49e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ENO2—hematologic cancer	3.75e-06	9.34e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NUP98—hematologic cancer	3.72e-06	9.27e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—IDH1—hematologic cancer	3.69e-06	9.2e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—MTHFR—hematologic cancer	3.69e-06	9.2e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CD44—hematologic cancer	3.69e-06	9.2e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NQO1—hematologic cancer	3.69e-06	9.2e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NUP98—hematologic cancer	3.69e-06	9.19e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TXN—hematologic cancer	3.65e-06	9.1e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCC3—hematologic cancer	3.65e-06	9.1e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTO1—hematologic cancer	3.65e-06	9.1e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTT1—hematologic cancer	3.64e-06	9.06e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.61e-06	9.01e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ADCY7—hematologic cancer	3.61e-06	9e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NCOA3—hematologic cancer	3.61e-06	9e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NUP214—hematologic cancer	3.59e-06	8.94e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.58e-06	8.92e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.58e-06	8.92e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.58e-06	8.92e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SPHK1—hematologic cancer	3.57e-06	8.91e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—FHL2—hematologic cancer	3.57e-06	8.89e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NUP214—hematologic cancer	3.56e-06	8.86e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SDC1—hematologic cancer	3.55e-06	8.85e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.52e-06	8.77e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ABCG2—hematologic cancer	3.52e-06	8.76e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—MTR—hematologic cancer	3.52e-06	8.76e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AGRN—hematologic cancer	3.5e-06	8.71e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYCS—hematologic cancer	3.49e-06	8.7e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.48e-06	8.68e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—MTR—hematologic cancer	3.48e-06	8.68e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	3.47e-06	8.65e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ENO2—hematologic cancer	3.45e-06	8.59e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—UGT1A1—hematologic cancer	3.43e-06	8.56e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ENO2—hematologic cancer	3.42e-06	8.51e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.39e-06	8.46e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.35e-06	8.35e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.34e-06	8.33e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.34e-06	8.32e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.34e-06	8.32e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—IDH2—hematologic cancer	3.32e-06	8.26e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HMMR—hematologic cancer	3.32e-06	8.26e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.31e-06	8.26e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SDC1—hematologic cancer	3.27e-06	8.14e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.26e-06	8.13e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.26e-06	8.11e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SDC1—hematologic cancer	3.24e-06	8.07e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.2e-06	7.98e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NUP98—hematologic cancer	3.15e-06	7.86e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.12e-06	7.78e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.12e-06	7.77e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CG—hematologic cancer	3.1e-06	7.73e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.09e-06	7.71e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTP1—hematologic cancer	3.08e-06	7.67e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.06e-06	7.63e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.06e-06	7.63e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.05e-06	7.61e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NUP214—hematologic cancer	3.04e-06	7.57e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CA9—hematologic cancer	3.03e-06	7.55e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ACP5—hematologic cancer	3.03e-06	7.55e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CD44—hematologic cancer	3.02e-06	7.53e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NQO1—hematologic cancer	3.02e-06	7.53e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.01e-06	7.49e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.99e-06	7.46e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.98e-06	7.42e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MTR—hematologic cancer	2.98e-06	7.42e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCG2—hematologic cancer	2.98e-06	7.42e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.96e-06	7.37e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.92e-06	7.28e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ENO2—hematologic cancer	2.92e-06	7.28e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ABCB1—hematologic cancer	2.91e-06	7.26e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CREBBP—hematologic cancer	2.88e-06	7.17e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYCS—hematologic cancer	2.86e-06	7.12e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—IDH1—hematologic cancer	2.85e-06	7.1e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	2.84e-06	7.08e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTT1—hematologic cancer	2.83e-06	7.06e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NCOR1—hematologic cancer	2.83e-06	7.05e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTM1—hematologic cancer	2.83e-06	7.05e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.82e-06	7.02e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TXN—hematologic cancer	2.82e-06	7.02e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.82e-06	7.02e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.79e-06	6.95e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CD44—hematologic cancer	2.78e-06	6.92e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NQO1—hematologic cancer	2.78e-06	6.92e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SDC1—hematologic cancer	2.77e-06	6.9e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.76e-06	6.87e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CD44—hematologic cancer	2.75e-06	6.86e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NQO1—hematologic cancer	2.75e-06	6.86e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CD—hematologic cancer	2.73e-06	6.8e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.7e-06	6.72e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALB—hematologic cancer	2.69e-06	6.71e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.65e-06	6.6e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.64e-06	6.59e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYCS—hematologic cancer	2.63e-06	6.55e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.61e-06	6.51e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.61e-06	6.5e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYCS—hematologic cancer	2.61e-06	6.49e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.59e-06	6.45e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.58e-06	6.42e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.58e-06	6.42e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3R1—hematologic cancer	2.58e-06	6.42e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.56e-06	6.37e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.52e-06	6.28e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.51e-06	6.26e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—MTHFR—hematologic cancer	2.5e-06	6.23e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.5e-06	6.22e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.44e-06	6.07e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NUP98—hematologic cancer	2.43e-06	6.06e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.39e-06	5.94e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CB—hematologic cancer	2.38e-06	5.93e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.36e-06	5.89e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.36e-06	5.89e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NQO1—hematologic cancer	2.35e-06	5.86e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CD44—hematologic cancer	2.35e-06	5.86e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NUP214—hematologic cancer	2.35e-06	5.84e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.33e-06	5.81e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.32e-06	5.77e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.32e-06	5.77e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.32e-06	5.77e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.3e-06	5.74e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTR—hematologic cancer	2.3e-06	5.73e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.3e-06	5.73e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.3e-06	5.72e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ENO2—hematologic cancer	2.25e-06	5.61e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYCS—hematologic cancer	2.23e-06	5.55e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.22e-06	5.54e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.21e-06	5.51e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.2e-06	5.49e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.19e-06	5.47e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.19e-06	5.45e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.17e-06	5.42e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SDC1—hematologic cancer	2.14e-06	5.32e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.13e-06	5.31e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.13e-06	5.31e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.11e-06	5.26e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.11e-06	5.26e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CG—hematologic cancer	2.1e-06	5.23e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTEN—hematologic cancer	2.06e-06	5.12e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.05e-06	5.1e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.99e-06	4.96e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTP1—hematologic cancer	1.96e-06	4.89e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—EP300—hematologic cancer	1.96e-06	4.88e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CREBBP—hematologic cancer	1.95e-06	4.85e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.9e-06	4.73e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.88e-06	4.69e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.87e-06	4.65e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.86e-06	4.63e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CD—hematologic cancer	1.85e-06	4.6e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALB—hematologic cancer	1.82e-06	4.54e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NQO1—hematologic cancer	1.82e-06	4.53e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CD44—hematologic cancer	1.82e-06	4.53e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.8e-06	4.49e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.8e-06	4.49e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.8e-06	4.49e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3R1—hematologic cancer	1.74e-06	4.35e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.72e-06	4.28e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYCS—hematologic cancer	1.72e-06	4.28e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.71e-06	4.26e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.64e-06	4.1e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CB—hematologic cancer	1.61e-06	4.01e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.59e-06	3.97e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.59e-06	3.97e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.58e-06	3.94e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.57e-06	3.91e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.52e-06	3.77e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.51e-06	3.77e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALB—hematologic cancer	1.49e-06	3.72e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.47e-06	3.65e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.45e-06	3.62e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.45e-06	3.61e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.43e-06	3.57e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.43e-06	3.56e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.41e-06	3.5e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.39e-06	3.47e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.39e-06	3.47e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTEN—hematologic cancer	1.39e-06	3.47e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.39e-06	3.46e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.38e-06	3.43e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALB—hematologic cancer	1.37e-06	3.42e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALB—hematologic cancer	1.36e-06	3.39e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.34e-06	3.34e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—EP300—hematologic cancer	1.33e-06	3.31e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.32e-06	3.28e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.31e-06	3.27e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.3e-06	3.24e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.24e-06	3.09e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.23e-06	3.07e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.21e-06	3.02e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.2e-06	2.99e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKT1—hematologic cancer	1.18e-06	2.95e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.18e-06	2.93e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALB—hematologic cancer	1.16e-06	2.9e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTEN—hematologic cancer	1.14e-06	2.84e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.11e-06	2.77e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—EP300—hematologic cancer	1.09e-06	2.7e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTEN—hematologic cancer	1.05e-06	2.61e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTEN—hematologic cancer	1.04e-06	2.59e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.03e-06	2.58e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.03e-06	2.56e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—EP300—hematologic cancer	9.99e-07	2.49e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—EP300—hematologic cancer	9.9e-07	2.47e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CA—hematologic cancer	9.81e-07	2.45e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.59e-07	2.39e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.09e-07	2.26e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALB—hematologic cancer	8.97e-07	2.24e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTEN—hematologic cancer	8.87e-07	2.21e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.58e-07	2.14e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—EP300—hematologic cancer	8.46e-07	2.11e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CA—hematologic cancer	8.03e-07	2e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKT1—hematologic cancer	8.02e-07	2e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.92e-07	1.97e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CA—hematologic cancer	7.39e-07	1.84e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.32e-07	1.82e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTEN—hematologic cancer	6.85e-07	1.71e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKT1—hematologic cancer	6.56e-07	1.63e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—EP300—hematologic cancer	6.53e-07	1.63e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CA—hematologic cancer	6.26e-07	1.56e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKT1—hematologic cancer	6.03e-07	1.5e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKT1—hematologic cancer	5.98e-07	1.49e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKT1—hematologic cancer	5.11e-07	1.27e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.83e-07	1.2e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKT1—hematologic cancer	3.95e-07	9.83e-06	CbGpPWpGaD
